Califf: Rare Disease Hub Will Develop Methods To Guide Approvability Determinations

 
• By Sarah Karlin-Smith

The US FDA commissioner also said the hub is looking for an executive director who will work with the CBER and CDER heads, who will serve as co-leads. 

FDA Commissioner Robert Califf speaks at a webinar sponsored by the Alliance for a Stronger FDA
FDA Commissioner Robert Califf discussed the FDA's new rare disease hub during a 27 September Alliance for a Stronger FDA event. • Source: Screenshot from Alliance for Stronger FDA webinar

More from Rare Diseases

More from Pink Sheet